Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes. - Sørensen, Kathrine Kold; Yazdanfard, Puriya Daniel Würtz; Zareini, Bochra; Pedersen-Bjergaard, Ulrik; Kosjerina, Vanja; Andersen, Mikkel Porsborg; Munch, Anders; Ohlendorff, Johan Sebastian; Schmid, Stefanie; Lanzinger, Stefanie; Choudhary, Pratik; Gillies, Clare; et al. (Cardiovascular Diabetology, 2025)